CFRXQ vs REGN: Which Stock is Better?
Side-by-side comparison of ContraFect Corporation and Regeneron Pharmaceuticals Inc in 2026
CFRXQ
ContraFect Corporation
—
REGN
Regeneron Pharmaceuticals Inc
$635.45
Key Metrics Comparison
| Metric | CFRXQ | REGN | Winner |
|---|---|---|---|
| Market Cap | $0.00M | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze CFRXQ
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CFRXQ or REGN a better investment?
Comparing CFRXQ and REGN: ContraFect Corporation has a market cap of $0.00M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CFRXQ and REGN?
CFRXQ (ContraFect Corporation) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CFRXQ or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CFRXQ or REGN?
Both CFRXQ and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: CFRXQ or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: CFRXQ or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $0.00M for CFRXQ.
Should I buy CFRXQ or REGN in 2026?
Both CFRXQ and REGN have investment merit. CFRXQ trades at $N/A while REGN trades at $635.45. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CFRXQ and REGN stock?
Key differences: Market Cap ($0.00M vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy CFRXQ or REGN in 2026?
The choice between CFRXQ and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CFRXQ and REGN?
CFRXQ (ContraFect Corporation) has a market cap of $0.00M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.